Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/21/2007 | CA2650127A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
12/20/2007 | US20070294791 Inbred sweet corn line R660K |
12/20/2007 | US20070294790 Desaturase Enzymes |
12/20/2007 | US20070294788 Transposable Elements in Rice and Methods of Use |
12/20/2007 | US20070294787 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of novel delta endotoxin genes and methods for their use |
12/20/2007 | US20070294786 Fructan Biosynthetic Enzymes |
12/20/2007 | US20070294780 Facilitation of oocyte, zygote and pre-implantation embryo maturation |
12/20/2007 | US20070293941 RGD peptide attached to bioabsorbable stents |
12/20/2007 | US20070293545 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
12/20/2007 | US20070293535 Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the Dame |
12/20/2007 | US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade |
12/20/2007 | US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
12/20/2007 | US20070293522 2,4-pyrimidinediamine compounds and their uses |
12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
12/20/2007 | US20070293499 Intracellular Kinase Inhibitors |
12/20/2007 | US20070293467 Demethyl-Cantharidin Platinum Complex Isomers and Their Use |
12/20/2007 | US20070293451 Regulation ao ApoB by Hsp110 proteins and related compositions and methods |
12/20/2007 | US20070293448 Synthetic gagpol genes and their uses |
12/20/2007 | US20070293429 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
12/20/2007 | US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof |
12/20/2007 | US20070293424 Antitumoral and Antiviral Peptides |
12/20/2007 | US20070292953 Disarmed Agrobacterium Strains, Ri-Plasmids, and Methods of Transformation Based Thereon |
12/20/2007 | US20070292951 Media and methods for culturing plant embryos |
12/20/2007 | US20070292950 Support for Cultivating Biological Material |
12/20/2007 | US20070292949 Serum-free media and their uses for chondrocyte expansion |
12/20/2007 | US20070292948 Obtained by introducing modified embryonic stem cells into early stage embryo, then implanting the manipulated embryo into surrogate mother; transfection; deletions, tumor suppressor genes; induction of oncogene following administration of tetracycline analog results in development of tumor |
12/20/2007 | US20070292947 Novgel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
12/20/2007 | US20070292946 Cell detachment method |
12/20/2007 | US20070292945 Cell Culture Apparatus and Methods |
12/20/2007 | US20070292944 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
12/20/2007 | US20070292922 Regulated expression of recombinant proteins from adeno-associated viral vectors |
12/20/2007 | US20070292921 tRNA synthetases, metRS |
12/20/2007 | US20070292920 Neurotoxins with enhanced target specificity |
12/20/2007 | US20070292915 Human OCT-2 Variant Peptide Chains, Nucleic Acids, and Methods |
12/20/2007 | US20070292910 Hematopoietic and umbilical cord progenitor cell culture; improving tissue engraft; tissue engineering and repair; regenerative medicine |
12/20/2007 | US20070292898 Functional Screening Assay |
12/20/2007 | US20070292885 Human cdnas and proteins and uses thereof |
12/20/2007 | US20070292881 Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis |
12/20/2007 | US20070292872 analysis of detecting the presence of expression of detectable marker; cell differentiation of interest osteoblasts, adipocytes, myoblasts, chondroblasts; treatment of osteogenesis, immunomodulatory agents, cell or tissue transplantation; tissue engineering |
12/20/2007 | US20070292847 nucleic acid molecule encoding a protein that hydrolyzes cyclic adenosine mono-phosphate (cAMP); leishmaniasis |
12/20/2007 | US20070292836 Methods for sorting undifferentiated cells and uses thereof |
12/20/2007 | US20070292581 Lipoxygenase |
12/20/2007 | US20070292514 Bioengineered Intervertebral Discs and Methods for Their Preparation |
12/20/2007 | US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
12/20/2007 | US20070292448 Preloaded dendritic cell vaccines for treating cancer |
12/20/2007 | US20070292439 B cell-related cancers and solid tumors, and diseases or disorders that have an autoimmune and/or inflammatory component, including organ and tissue transplant rejection |
12/20/2007 | US20070292438 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
12/20/2007 | US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease |
12/20/2007 | US20070292431 4-1Bb Receptors are Expressed on Regulatory T-Cells |
12/20/2007 | US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof |
12/20/2007 | US20070292426 Methods and compositions based on Shiga toxin type 1 protein |
12/20/2007 | US20070292424 Novel human eosinophil-derived basic protein |
12/20/2007 | US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance |
12/20/2007 | US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer |
12/20/2007 | US20070292414 Compositions enriched in neoplastic stem cells and methods comprising same |
12/20/2007 | US20070292411 Antibodies That Immunospecifically Bind to TRAIL Receptors |
12/20/2007 | US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders |
12/20/2007 | US20070292401 Soft tissue repair and regeneration using stem cell products |
12/20/2007 | US20070292400 Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
12/20/2007 | US20070292399 Co-culture of placental stem cells and stem cells from a second source |
12/20/2007 | US20070292398 Differentiation of multi-lineage progenitor cells to hepatocytes |
12/20/2007 | US20070292389 Method for the Purification and Amplification of Tumoral Stem Cells |
12/20/2007 | US20070292388 In vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in medium comprising ligands of EGF receptor and GP130 receptor, such as EGF and LIF; insulin secreting cells obtainable by this method provide means for treatment of diabetes |
12/20/2007 | US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6 |
12/20/2007 | US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk |
12/19/2007 | EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use |
12/19/2007 | EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
12/19/2007 | EP1867717A1 Method of ameliorating symptom caused by mood disturbance |
12/19/2007 | EP1867716A1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same |
12/19/2007 | EP1867714A1 5-fluorouracil-resistant bacteria and method for production thereof |
12/19/2007 | EP1866429A2 Methods of islet isolation and transplantation |
12/19/2007 | EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
12/19/2007 | EP1866411A1 Improved proliferative capacity using cell-cell fusion generated hybrids |
12/19/2007 | EP1866409A2 Parathyroid and thymus transplantation in digeorge syndrome subjects |
12/19/2007 | EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma |
12/19/2007 | EP1865884A1 Skin substitutes with improved purity |
12/19/2007 | EP1557469B1 Method of expressing protein having unnatural amino acid integrated thereinto |
12/19/2007 | EP1303599B1 Methylated nucleotide regulation of upa gene expression |
12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
12/19/2007 | EP1194033B1 Transgenically produced antithrombin iii and mutants thereof |
12/19/2007 | EP1115432B2 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge |
12/19/2007 | EP0954578B1 Glycoprotein hormone (tsh) superagonists |
12/19/2007 | EP0772689B1 Retroviral vectors having a reduced recombination rate |
12/19/2007 | EP0652950B1 Generation of xenogeneic antibodies |
12/19/2007 | EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
12/19/2007 | EP0570422B1 Stamen-specific promoters from corn |
12/19/2007 | CN101090968A Selection of host cells expressing protein at high levels |
12/19/2007 | CN101089183A Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds |
12/19/2007 | CN101089176A Stem cell separating liquid and its separating method |
12/19/2007 | CN101088561A Anti hepatitis c virus antibody and uses thereof |
12/19/2007 | CN101088323A Process of in vitro culturing adventitious bud with cotton cotyledon to induce plant regeneration |
12/19/2007 | CN100355896C Method for breeding halophyte of double transgene |
12/19/2007 | CN100355894C Method for cultivating perennial ryegrass with improved drought resistance |
12/19/2007 | CN100355882C Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody |
12/19/2007 | CN100355881C Plant expression carrier plasmid for hepatitis B gene, hepatitis B gene transgenic cell line and its industrialization production application |
12/19/2007 | CN100355880C Method for optimizing culture-medium of high-flux mammal |
12/19/2007 | CN100355334C Tissue-culturing and seedling-growing method for rosa canina |
12/18/2007 | US7309822 Inbred corn line G0302 |
12/18/2007 | US7309818 Soybean cultivar S050222 |